Analytical challenges for measuring steroid responses to stress, neurodegeneration and injury in the central nervous system

Steroids

Volumn 103, Issue , 2015, Pages 42-57

  Schumacher, Michael ^a   Guennoun, Rachida ^a   Mattern, Claudia ^b   Oudinet, Jean Paul ^a   Labombarda, Florencia ^c   De Nicola, Alejandro F ^c   Liere, Philippe ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b M et P Pharma AG   (Switzerland)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Alzheimers disease; Brain injury; Gas chromatography; Liquid chromatography; Mass spectrometry; Multiple sclerosis; Neurosteroids; Radioimmunoassay; Stress; Tandem mass spectrometry

Indexed keywords

MYELIN; NEUROSTEROID; PROGESTERONE; STEROID HORMONE; STEROID;

ACUTE STRESS; ALZHEIMER DISEASE; ANALYTIC METHOD; BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN LEVEL; DEPRESSION; EMOTIONAL DISORDER; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOTSHOCK; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MENTAL STRESS; MULTIPLE SCLEROSIS; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; POSTTRAUMATIC STRESS DISORDER; PROGESTERONE BLOOD LEVEL; RADIOIMMUNOASSAY; REFERENCE VALUE; REVIEW; STEROID ANALYSIS; STEROID BLOOD LEVEL; STEROIDOGENESIS; STRESS; TANDEM MASS SPECTROMETRY; TRAUMATIC BRAIN INJURY; ADULT; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS;

ADULT; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM; HUMANS; NEURODEGENERATIVE DISEASES; RADIOIMMUNOASSAY; STEROIDS; STRESS, PHYSIOLOGICAL; TANDEM MASS SPECTROMETRY;

EID: 84945436320     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2015.08.013     Document Type: Review

References (245)

1. A.F. De Nicola, F. Labombarda, M.C. Deniselle, S.L. Gonzalez, L. Garay, M. Meyer, and et al. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration Front. Neuroendocrinol. 30 2009 173 187
2. R.C. Melcangi, G. Panzica, and L.M. Garcia-Segura Neuroactive steroids: focus on human brain Neuroscience 191 2011 1 5
3. R.D. Brinton Neurosteroids as regenerative agents in the brain: therapeutic implications Nat. Rev. Endocrinol. 9 2013 241 250
4. M. Schumacher, C. Mattern, A. Ghoumari, J.P. Oudinet, P. Liere, F. Labombarda, and et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors Prog. Neurobiol. 113 2014 6 39
5. M.A. Arevalo, I. Azcoitia, and L.M. Garcia-Segura The neuroprotective actions of oestradiol and oestrogen receptors Nat. Rev. Neurosci. 16 2015 17 29
6. D.G. Stein Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update Neuroscience 191 2011 101 106
7. C. Schule, D. Eser, T.C. Baghai, C. Nothdurfter, J.S. Kessler, and R. Rupprecht Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience 191 2011 55 77
8. R. Rupprecht, V. Papadopoulos, G. Rammes, T.C. Baghai, J. Fan, N. Akula, and et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders Nat. Rev. Drug Discov. 9 2010 971 988
9. A.M. Ghoumari, C. Ibanez, M. El-Etr, P. Leclerc, B. Eychenne, B.W. Malley, and et al. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum J. Neurochem. 86 2003 848 859
10. N.J. MacLusky, T. Hajszan, J. Prange-Kiel, and C. Leranth Androgen modulation of hippocampal synaptic plasticity Neuroscience 138 2006 957 965
11. C.K. Wagner The many faces of progesterone: a role in adult and developing male brain Front. Neuroendocrinol. 27 2006 340 359
12. S.H. Mellon Neurosteroid regulation of central nervous system development Pharmacol. Ther. 116 2007 107 124
13. M.M. McCarthy Estradiol and the developing brain Physiol. Rev. 88 2008 91 124
14. M. Schumacher, R. Hussain, N. Gago, J.P. Oudinet, C. Mattern, and A.M. Ghoumari Progesterone synthesis in the nervous system: implications for myelination and myelin repair Front. Neurosci. 6 2012 10
15. K. Tsutsui Neurosteroid biosynthesis and action during cerebellar development Cerebellum 11 2012 414 415
16. M. Bondesson, R. Hao, C.Y. Lin, C. Williams, and J.A. Gustafsson Estrogen receptor signaling during vertebrate development Biochim. Biophys. Acta 1849 2015 142 151
17. L.D. Griffin, W. Gong, L. Verot, and S.H. Mellon Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone Nat. Med. 10 2004 704 711
18. J.J. Hirst, T. Yawno, P. Nguyen, and D.W. Walker Stress in pregnancy activates neurosteroid production in the fetal brain Neuroendocrinology 84 2006 264 274
19. T. Yawno, E.B. Yan, D.W. Walker, and J.J. Hirst Inhibition of neurosteroid synthesis increases asphyxia-induced brain injury in the late gestation fetal sheep Neuroscience 146 2007 1726 1733
20. C.A. Frye, J.J. Hirst, P.J. Brunton, and J.A. Russell Neurosteroids for a successful pregnancy Stress 14 2011 1 5
21. P.J. Brunton, J.A. Russell, and J.J. Hirst Allopregnanolone in the brain: protecting pregnancy and birth outcomes Prog. Neurobiol. 113 2014 106 136
22. F. Bosse, K. Hasenpusch-Theil, P. Kury, and H.W. Muller Gene expression profiling reveals that peripheral nerve regeneration is a consequence of both novel injury-dependent and reactivated developmental processes J. Neurochem. 96 2006 1441 1457
23. J. Chen, S.Y. Leong, and M. Schachner Differential expression of cell fate determinants in neurons and glial cells of adult mouse spinal cord after compression injury Eur. J. Neurosci. 22 2005 1895 1906
24. S.P. Fancy, J.R. Chan, S.E. Baranzini, R.J. Franklin, and D.H. Rowitch Myelin regeneration: a recapitulation of development? Annu. Rev. Neurosci. 34 2011 21 43
25. P. Liere, and M. Schumacher Mass spectrometric analysis of steroids: all that glitters is not gold Expert Rev. Endocrinol. Metabol. 10 2015 463 465
26. S.A. Berson, and R.S. Yalow Quantitative aspects of the reaction between insulin and insulin-binding antibody J. Clin. Invest. 38 1959 1996 2016
27. G.E. Abraham Solid-phase radioimmunoassay of estradiol-17 beta J. Clin. Endocrinol. Metab. 29 1969 866 870
28. G.E. Abraham, R. Swerdloff, D. Tulchinsky, and W.D. Odell Radioimmunoassay of plasma progesterone J. Clin. Endocrinol. Metab. 32 1971 619 624
29. G.E. Abraham, J.E. Buster, F.W. Kyle, P.C. Corrales, and R.C. Teller Radioimmunoassay of plasma pregnenolone J. Clin. Endocrinol. Metab. 37 1973 40 45
30. G.E. Abraham Radioimmunoassay of steroids in biological fluids J. Steroid Biochem. 6 1975 261 270
31. A.M. Matsumoto, and W.J. Bremner Serum testosterone assays - accuracy matters J. Clin. Endocrinol. Metab. 89 2004 520 524
32. K.K. Miller, W. Rosner, H. Lee, J. Hier, G. Sesmilo, D. Schoenfeld, and et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods J. Clin. Endocrinol. Metab. 89 2004 525 533
33. F.Z. Stanczyk, J. Jurow, and A.W. Hsing Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies Cancer Epidemiol. Biomarkers Prev. 19 2010 903 906
34. G.E. Abraham, R.S. Swerdloff, D. Tulchinsky, K. Hopper, and W.D. Odell Radioimmunoassay of plasma 17-hydroxyprogesterone J. Clin. Endocrinol. Metab. 33 1971 42 46
35. C. Wang, S. Shiraishi, A. Leung, S. Baravarian, L. Hull, V. Goh, and et al. Validation of a testosterone and dihydrotestosterone liquid chromatography tandem mass spectrometry assay: interference and comparison with established methods Steroids 73 2008 1345 1352
36. J.S. Lee, B. Ettinger, F.Z. Stanczyk, E. Vittinghoff, V. Hanes, J.A. Cauley, and et al. Comparison of methods to measure low serum estradiol levels in postmenopausal women J. Clin. Endocrinol. Metab. 91 2006 3791 3797
37. I.T. Huhtaniemi, A. Tajar, D.M. Lee, T.W. O'Neill, J.D. Finn, G. Bartfai, and et al. Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men Eur. J. Endocrinol. 166 2012 983 991
38. A.W. Hsing, F.Z. Stanczyk, A. Belanger, P. Schroeder, L. Chang, R.T. Falk, and et al. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry Cancer Epidemiol. Biomarkers Prev. 16 2007 1004 1008
39. R.J. Santen, L. Demers, S. Ohorodnik, J. Settlage, P. Langecker, D. Blanchett, and et al. Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy Steroids 72 2007 666 671
40. J.M. Faupel-Badger, B.J. Fuhrman, X. Xu, R.T. Falk, L.K. Keefer, T.D. Veenstra, and et al. Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens Cancer Epidemiol. Biomarkers Prev. 19 2010 292 300
41. I.A. Blair Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future Steroids 75 2010 297 306
42. C. Ohlsson, M.E. Nilsson, A. Tivesten, H. Ryberg, D. Mellstrom, M.K. Karlsson, and et al. Comparisons of immunoassay and mass spectrometry measurements of serum estradiol levels and their influence on clinical association studies in men J. Clin. Endocrinol. Metab. 98 2013 E1097 E1102
43. M.E. Nilsson, L. Vandenput, A. Tivesten, A.K. Norlen, M.K. Lagerquist, S.H. Windahl, and et al. Measurement of a comprehensive sex steroid profile in rodent serum by high-sensitive gas chromatography-tandem mass spectrometry Endocrinology 156 2015 2492 2502
44. H. Ketha, S. Kaur, S.K. Grebe, and R.J. Singh Clinical applications of LC-MS sex steroid assays: evolution of methodologies in the 21st century Curr. Opin. Endocrinol. Diabetes Obes. 21 2014 217 226
45. D.J. Handelsman, and L. Wartofsky Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism J. Clin. Endocrinol. Metab. 98 2013 3971 3973
46. Y.B. Saalmann, M.T. Kirkcaldie, S. Waldron, and M.B. Calford Cellular distribution of the GABAA receptor-modulating 3alpha-hydroxy, 5alpha-reduced pregnane steroids in the adult rat brain J. Neuroendocrinol. 19 2007 272 284
47. J.B. Cook, S.M. Nelli, M.R. Neighbors, D.H. Morrow, T.K. O'Buckley, A.M. Maldonado-Devincci, and et al. Ethanol alters local cellular levels of (3alpha,5alpha)-3-hydroxypregnan-20-one (3alpha,5alpha-THP) independent of the adrenals in subcortical brain regions Neuropsychopharmacology 39 2014 1978 1987
48. J.B. Cook, A.M. Dumitru, T.K. O'Buckley, and A.L. Morrow Ethanol administration produces divergent changes in GABAergic neuroactive steroid immunohistochemistry in the rat brain Alcohol. Clin. Exp. Res. 38 2014 90 99
49. J.B. Cook, D.F. Werner, A.M. Maldonado-Devincci, M.N. Leonard, K.R. Fisher, T.K. O'Buckley, and et al. Overexpression of the steroidogenic enzyme cytochrome P450 side chain cleavage in the ventral tegmental area increases 3alpha,5alpha-THP and reduces long-term operant ethanol self-administration J. Neurosci. 34 2014 5824 5834
50. A.M. Maldonado-Devincci, M.C. Beattie, D.H. Morrow, R.E. McKinley, J.B. Cook, T.K. O'Buckley, and et al. Reduction of circulating and selective limbic brain levels of (3alpha,5alpha)-3-hydroxy-pregnan-20-one (3alpha,5alpha-THP) following forced swim stress in C57BL/6J mice Psychopharmacology 231 2014 3281 3292
51. Q.G. Zhang, R. Wang, H. Tang, Y. Dong, A. Chan, G.R. Sareddy, and et al. Brain-derived estrogen exerts anti-inflammatory and neuroprotective actions in the rat hippocampus Mol. Cell. Endocrinol. 389 2014 84 91
52. U.H. Stenman Standardization of hormone determinations Best Pract. Res. Clin. Endocrinol. Metab. 27 2013 823 830
53. A.H. Wu, and D. French Implementation of liquid chromatography/mass spectrometry into the clinical laboratory Clin. Chim. Acta 420 2013 4 10
54. J. Sjovall, and R. Vihko Determination of androsterone and dehydroepiandrosterone sulfates in human serum by gas-liquid chromatography Steroids 6 1965 597 604
55. J. Sjovall, and M. Axelson Newer approaches to the isolation, identification, and quantitation of steroids in biological materials Vitam. Horm. 39 1982 31 144
56. D.L. Cheney, D. Uzunov, E. Costa, and A. Guidotti Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats J. Neurosci. 15 1995 4641 4650
57. M. Hill, A. Parizek, D. Cibula, R. Kancheva, J.E. Jirasek, M. Jirkovska, and et al. Steroid metabolome in fetal and maternal body fluids in human late pregnancy J. Steroid Biochem. Mol. Biol. 122 2010 114 132
58. A. Hertig, P. Liere, N. Chabbert-Buffet, J. Fort, A. Pianos, B. Eychenne, and et al. Steroid profiling in preeclamptic women: evidence for aromatase deficiency Am. J. Obstet. Gynecol. 203 477 2010 e1 e9
59. F.Z. Stanczyk, and N.J. Clarke Advantages and challenges of mass spectrometry assays for steroid hormones J. Steroid Biochem. Mol. Biol. 121 2010 491 495
60. M. Bicikova, M. Hill, D. Ripova, P. Mohr, and R. Hampl Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia J. Steroid Biochem. Mol. Biol. 133 2013 77 83
61. K.M. McNamara, D.T. Harwood, U. Simanainen, K.A. Walters, M. Jimenez, and D.J. Handelsman Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry J. Steroid Biochem. Mol. Biol. 121 2010 611 618
62. M.J. Ebner, D.I. Corol, H. Havlikova, J.W. Honour, and J.P. Fry Identification of neuroactive steroids and their precursors and metabolites in adult male rat brain Endocrinology 147 2006 179 190
63. P. Liere, A. Pianos, B. Eychenne, A. Cambourg, K. Bodin, W. Griffiths, and et al. Analysis of pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key J. Lipid Res. 50 2009 2430 2444
64. S. Aggarwal, L. Yurlova, and M. Simons Central nervous system myelin: structure, synthesis and assembly Trends Cell Biol. 21 2011 585 593
65. G. Saher, and M. Simons Cholesterol and myelin biogenesis Subcell. Biochem. 51 2010 489 508
66. M.N. Rasband, and W.B. Macklin Myelin structure and biochemistry S.T. Brady, G.J. Siegel, R.W. Albers, D.L. Price, Basic Neurochemistry eighth ed. 2011 Elsevier 205 220
67. M.D. Taves, C. Ma, S.A. Heimovics, C.J. Saldanha, and K.K. Soma Measurement of steroid concentrations in brain tissue: methodological considerations Front. Endocrinol. 2 2011 39
68. C. Corpéchot, P. Robel, M. Axelson, J. Sjövall, and E.E. Baulieu Characterization and measurement of dehydroepiandrosterone sulfate in the rat brain Proc. Natl. Acad. Sci. USA 78 1981 4704 4707
69. C. Corpéchot, M. Synguelakis, S. Talha, M. Axelson, J. Sjövall, R. Vihko, and et al. Pregnenolone and its sulfate ester in the rat brain Brain Res. 270 1983 119 125
70. C. Mathur, V.V. Prasad, V.S. Raju, M. Welch, and S. Lieberman Steroids and their conjugates in the mammalian brain Proc. Natl. Acad. Sci. USA 90 1993 85 88
71. J.F. Flood, J.E. Morley, and E. Roberts Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it Proc. Natl. Acad. Sci. USA 89 1992 1567 1571
72. J.F. Flood, J.E. Morley, and E. Roberts Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive Proc. Natl. Acad. Sci. USA 92 1995 10806 10810
73. M. Schumacher, P. Liere, Y. Akwa, K. Rajkowski, W. Griffiths, K. Bodin, and et al. Pregnenolone sulfate in the brain: a controversial neurosteroid Neurochem. Int. 52 2008 522 540
74. M. Vallée, W. Mayo, M. Darnaudéry, C. Corpéchot, J. Young, M. Koehl, and et al. Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus Proc. Natl. Acad. Sci. USA 94 1997 14865 14870
75. W.J. Griffiths, S. Liu, Y. Yang, R.H. Purdy, and J. Sjovall Nano-electrospray tandem mass spectrometry for the analysis of neurosteroid sulphates Rapid Commun. Mass Spectrom. 13 1999 1595 1610
76. K. Mitamura, M. Yatera, and K. Shimada Quantitative determination of pregnenolone 3-sulfate in rat brains using liquid chromatography/electrospray ionization-mass spectrometry Anal. Sci. 15 1999 951 955
77. S. Liu, J. Sjovall, and W.J. Griffiths Neurosteroids in rat brain: extraction, isolation, and analysis by nanoscale liquid chromatography-electrospray mass spectrometry Anal. Chem. 75 2003 5835 5846
78. S. Liu, W.J. Griffiths, and J. Sjovall Capillary liquid chromatography/electrospray mass spectrometry for analysis of steroid sulfates in biological samples Anal. Chem. 75 2003 791 797
79. T. Higashi, H. Sugitani, T. Yagi, and K. Shimada Studies on neurosteroids XVI. Levels of pregnenolone sulfate in rat brains determined by enzyme-linked immunosorbent assay not requiring solvolysis Biol. Pharm. Bull. 26 2003 709 711
80. T. Higashi, Y. Daifu, T. Ikeshima, T. Yagi, and K. Shimada Studies on neurosteroids XV. Development of enzyme-linked immunosorbent assay for examining whether pregnenolone sulfate is a veritable neurosteroid J. Pharm. Biomed. Anal. 30 2003 1907 1917
81. P. Liere, A. Pianos, B. Eychenne, A. Cambourg, S. Liu, W. Griffiths, and et al. Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain J. Lipid Res. 45 2004 2287 2302
82. W.A. Banks Brain meets body: the blood-brain barrier as an endocrine interface Endocrinology 153 2012 4111 4119
83. W.M. Pardridge Drug transport across the blood-brain barrier J. Cereb. Blood Flow Metab. 32 2012 1959 1972
84. S.K. Droste, L. de Groote, H.C. Atkinson, S.L. Lightman, J.M. Reul, and A.C. Linthorst Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress Endocrinology 149 2008 3244 3253
85. W.M. Pardridge, and L.J. Mietus Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone J. Clin. Invest. 64 1979 145 154
86. O.C. Meijer, E.C. de Lange, D.D. Breimer, A.G. de Boer, J.O. Workel, and E.R. De Kloet Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice Endocrinology 139 1998 1789 1793
87. M. Uhr, F. Holsboer, and M.B. Muller Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins J. Neuroendocrinol. 14 2002 753 759
88. J.C. Thiery, P. Robel, S. Canepa, B. Delaleu, V. Gayrard, N. Picard-Hagen, and et al. Passage of progesterone into the brain changes with photoperiod in the ewe Eur. J. Neurosci. 18 2003 895 901
89. J.C. Thiery, D. Lomet, M. Schumacher, P. Liere, H. Tricoire, A. Locatelli, and et al. Concentrations of estradiol in ewe cerebrospinal fluid are modulated by photoperiod through pineal-dependent mechanisms J. Pineal Res. 41 2006 306 312
90. E.E. Baulieu Neurosteroids: of the nervous system, by the nervous system, for the nervous system Recent Prog. Horm. Res. 52 1997 1 32
91. E.E. Baulieu, P. Robel, and M. Schumacher Neurosteroids: beginning of the story Int. Rev. Neurobiol. 46 2001 1 32
92. S.M. Paul, and R.H. Purdy Neuroactive steroids FASEB J. 6 1992 2311 2322
93. H.L. Koenig, M. Schumacher, B. Ferzaz, A.N. Do Thi, A. Ressouches, R. Guennoun, and et al. Progesterone synthesis and myelin formation by Schwann cells Science 268 1995 1500 1503
94. M. Verleye, Y. Akwa, P. Liere, N. Ladurelle, A. Pianos, B. Eychenne, and et al. The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain Pharmacol. Biochem. Behav. 82 2005 712 720
95. F. Labombarda, S. Gonzalez, M.C. Deniselle, L. Garay, R. Guennoun, M. Schumacher, and et al. Progesterone increases the expression of myelin basic protein and the number of cells showing NG(2) immunostaining in the lesioned spinal cord J. Neurotrauma 23 2006 181 192
96. T.H. Allen, H.J. Krzywicki, and J.E. Roberts Density, fat, water and solids in freshly isolated tissues J. Appl. Physiol. 14 1959 1005 1008
97. R. Green, W.G. Luttge, and R.E. Whalen Uptake and retention of tritiated estradiol in brain and peripheral tissues of male, female and neonatally androgenized female rats Endocrinology 85 1969 373 378
98. B.S. McEwen, and D.W. Pfaff Factors influencing sex hormone uptake by rat brain regions. I. Effects of neonatal treatment, hypophysectomy, and competing steroid on estradiol uptake Brain Res. 21 1970 1 16
99. 3H]5 alpha-dihydroprogesterone by rat brain and pituitary and effects of estradiol and time: tissue concentration of progesterone itself or specific metabolites? Endocrinology 104 1979 1418 1425
100. J. Young, C. Corpéchot, M. Perche, M. Haug, E.E. Baulieu, and P. Robel Neurosteroids: pharmacological effects of a 3 b-hydroxy-steroid dehydrogenase inhibitor Endocrine J. 2 1994 505 509
101. A. Korneyev, B.S. Pan, A. Polo, E. Romeo, A. Guidotti, and E. Costa Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo J. Neurochem. 61 1993 1515 1524
102. E. Romeo, S. Cavallaro, A. Korneyev, A.P. Kozikowski, D. Ma, A. Polo, and et al. Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex J. Pharmacol. Exp. Ther. 267 1993 462 471
103. M. Serra, P. Madau, M.F. Chessa, M. Caddeo, E. Sanna, G. Trapani, and et al. 2-Phenyl-imidazo[1,2-a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats Br. J. Pharmacol. 127 1999 177 187
104. D. Bitran, M. Foley, D. Audette, N. Leslie, and C.A. Frye Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat Psychopharmacology 151 2000 64 71
105. K. Morohaku, S.H. Pelton, D.J. Daugherty, W.R. Butler, W. Deng, and V. Selvaraj Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis Endocrinology 155 2014 89 97
106. V. Papadopoulos, Y. Aghazadeh, J. Fan, E. Campioli, B. Zirkin, and A. Midzak Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis Mol. Cell. Endocrinol. 408 2015 90 98
107. J. Fan, E. Campioli, A. Midzak, M. Culty, and V. Papadopoulos Conditional steroidogenic cell-targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation Proc. Natl. Acad. Sci. USA 112 2015 7261 7266
108. V. Selvaraj, and D.M. Stocco The changing landscape in translocator protein (TSPO) function Trends Endocrinol. Metab. 26 2015 341 348
109. J.J. Lacapere, and V. Papadopoulos Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis Steroids 68 2003 569 585
110. V. Papadopoulos, M. Baraldi, T.R. Guilarte, T.B. Knudsen, J.J. Lacapere, P. Lindemann, and et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol. Sci. 27 2006 402 409
111. R.H. Purdy, A.L. Morrow, P.H. Moore Jr., and S.M. Paul Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain Proc. Natl. Acad. Sci. USA 88 1991 4553 4557
112. M.L. Barbaccia, G. Roscetti, M. Trabucchi, R.H. Purdy, M.C. Mostallino, A. Concas, and et al. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations Br. J. Pharmacol. 120 1997 1582 1588
113. M.L. Barbaccia, G. Roscetti, M. Trabucchi, M.C. Mostallino, A. Concas, R.H. Purdy, and et al. Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress Neuroendocrinology 63 1996 166 172
114. M. Vallee, J.D. Rivera, G.F. Koob, R.H. Purdy, and R.L. Fitzgerald Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry Anal. Biochem. 287 2000 153 166
115. T. Higashi, A. Nagahama, N. Otomi, and K. Shimada Studies on neurosteroids XIX. Development and validation of liquid chromatography-tandem mass spectrometric method for determination of 5alpha-reduced pregnane-type neurosteroids in rat brain and serum J. Chromatogr. B 848 2007 188 199
116. V.K. Patchev, M. Shoaib, F. Holsboer, and O.F. Almeida The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus Neuroscience 62 1994 265 271
117. V.K. Patchev, A.H. Hassan, D.F. Holsboer, and O.F. Almeida The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus Neuropsychopharmacology 15 1996 533 540
118. P.J. Brunton, A.J. McKay, T. Ochedalski, A. Piastowska, E. Rebas, A. Lachowicz, and et al. Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone J. Neurosci. 29 2009 6449 6460
119. R.J. Handa, A.E. Kudwa, N.C. Donner, R.F. McGivern, and R. Brown Central 5-alpha reduction of testosterone is required for testosterone's inhibition of the hypothalamo-pituitary-adrenal axis response to restraint stress in adult male rats Brain Res. 1529 2013 74 82
120. V.K. Patchev, and O.F. Almeida Gonadal steroids exert facilitating and "buffering" effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hormone and corticosteroid receptor genes in rat brain J. Neurosci. 16 1996 7077 7084
121. T.D. Lund, L.R. Hinds, and R.J. Handa The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus J. Neurosci. 26 2006 1448 1456
122. R.J. Handa, D. Sharma, and R. Uht A role for the androgen metabolite, 5alpha androstane 3beta, 17beta diol (3beta-diol) in the regulation of the hypothalamo-pituitary-adrenal axis Front. Endocrinol. 2 2011 65
123. R.J. Handa, and M.J. Weiser Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis Front. Neuroendocrinol. 35 2014 197 220
124. E. Dong, K. Matsumoto, V. Uzunova, I. Sugaya, H. Takahata, H. Nomura, and et al. Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation Proc. Natl. Acad. Sci. USA 98 2001 2849 2854
125. M. Serra, M.G. Pisu, M. Littera, G. Papi, E. Sanna, F. Tuveri, and et al. Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain J. Neurochem. 75 2000 732 740
126. M. Serra, M.G. Pisu, I. Floris, and G. Biggio Social isolation-induced changes in the hypothalamic-pituitary-adrenal axis in the rat Stress 8 2005 259 264
127. B.S. McEwen Physiology and neurobiology of stress and adaptation: central role of the brain Physiol. Rev. 87 2007 873 904
128. A.M. Rasmusson, G. Pinna, P. Paliwal, D. Weisman, C. Gottschalk, D. Charney, and et al. Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder Biol. Psychiatry 60 2006 704 713
129. V. Michopoulos, S.D. Norrholm, and T. Jovanovic Diagnostic biomarkers for posttraumatic stress disorder: promising horizons from translational neuroscience research Biol. Psychiatry 2015
130. M.C. Morris, B.E. Compas, and J. Garber Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis Clin. Psychol. Rev. 32 2012 301 315
131. R. Yehuda Biology of posttraumatic stress disorder J. Clin. Psychiatry 62 Suppl. 17 2001 41 46
132. G. Pinna, and A.M. Rasmusson Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder Front. Cell. Neurosci. 8 2014 256
133. C. Schule, C. Nothdurfter, and R. Rupprecht The role of allopregnanolone in depression and anxiety Prog. Neurobiol. 113 2014 79 87
134. C. Nothdurfter, G. Rammes, T.C. Baghai, C. Schule, M. Schumacher, V. Papadopoulos, and et al. Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile J. Neuroendocrinol. 24 2012 82 92
135. N. Nguyen, E. Fakra, V. Pradel, E. Jouve, C. Alquier, M.E. Le Guern, and et al. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice Hum. Psychopharmacol. 21 2006 139 149
136. R. Rupprecht, G. Rammes, D. Eser, T.C. Baghai, C. Schule, C. Nothdurfter, and et al. Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects Science 325 2009 490 493
137. S. Moriam, and M.E. Sobhani Epigenetic effect of chronic stress on dopamine signaling and depression Genet. Epigenet. 5 2013 11 16
138. H.J. Krugers, P.J. Lucassen, H. Karst, and M. Joels Chronic stress effects on hippocampal structure and synaptic function: relevance for depression and normalization by anti-glucocorticoid treatment Front. Synaptic Neurosci. 2 2010 24
139. B.S. McEwen, and J.H. Morrison The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course Neuron 79 2013 16 29
140. F. Holsboer, and M. Ising Stress hormone regulation: biological role and translation into therapy Annu. Rev. Psychol. 61 81-109 2010 c1 c11
141. D.P. Uzunov, T.B. Cooper, E. Costa, and A. Guidotti Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography Proc. Natl. Acad. Sci. USA 93 1996 12599 12604
142. L.D. Griffin, and S.H. Mellon Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes Proc. Natl. Acad. Sci. USA 96 1999 13512 13517
143. V. Uzunova, Y. Sheline, J.M. Davis, A. Rasmusson, D.P. Uzunov, E. Costa, and et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine Proc. Natl. Acad. Sci. USA 95 1998 3239 3244
144. G. Pinna, E. Costa, and A. Guidotti SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake Curr. Opin. Pharmacol. 9 2009 24 30
145. R.C. Agis-Balboa, A. Guidotti, and G. Pinna 5alpha-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients Psychopharmacology 231 2014 3569 3580
146. E. Romeo, A. Strohle, G. Spalletta, F. di Michele, B. Hermann, F. Holsboer, and et al. Effects of antidepressant treatment on neuroactive steroids in major depression Am. J. Psychiatry 155 1998 910 913
147. A. Strohle, E. Romeo, B. Hermann, A. Pasini, G. Spalletta, F. di Michele, and et al. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery Biol. Psychiatry 45 1999 274 277
148. A. Strohle, A. Pasini, E. Romeo, B. Hermann, G. Spalletta, F. di Michele, and et al. Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression J. Psychiatr. Res. 34 2000 183 186
149. C. Schule, E. Romeo, D.P. Uzunov, D. Eser, F. di Michele, T.C. Baghai, and et al. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity Mol. Psychiatry 11 2006 261 272
150. J.C. Naylor, C.M. Hulette, D.C. Steffens, L.J. Shampine, J.F. Ervin, V.M. Payne, and et al. Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage J. Clin. Endocrinol. Metab. 93 2008 3173 3178
151. R. Kancheva, M. Hill, Z. Novak, J. Chrastina, L. Kancheva, and L. Starka Neuroactive steroids in periphery and cerebrospinal fluid Neuroscience 191 2011 22 27
152. R. Kancheva, M. Hill, Z. Novak, J. Chrastina, M. Velikova, L. Kancheva, and et al. Peripheral neuroactive steroids may be as good as the steroids in the cerebrospinal fluid for the diagnostics of CNS disturbances J. Steroid Biochem. Mol. Biol. 119 2010 35 44
153. D. Caruso, M. Pesaresi, F. Abbiati, D. Calabrese, S. Giatti, L.M. Garcia-Segura, and et al. Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats Psychoneuroendocrinology 38 2013 2278 2290
154. E. Seong, A.F. Seasholtz, and M. Burmeister Mouse models for psychiatric disorders Trends Genet. 18 2002 643 650
155. Y.S. Mineur, C. Belzung, and W.E. Crusio Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice Behav. Brain Res. 175 2006 43 50
156. M. Vallee Structure-activity relationship studies on neuroactive steroids in memory, alcohol and stress-related functions: a crucial benefit from endogenous level analysis Psychopharmacology 231 2014 3243 3255
157. R.C. Agis-Balboa, G. Pinna, F. Pibiri, B. Kadriu, E. Costa, and A. Guidotti Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice Proc. Natl. Acad. Sci. USA 104 2007 18736 18741
158. S. Luchetti, I. Huitinga, and D.F. Swaab Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis Neuroscience 191 2011 6 21
159. D.F. Swaab, A.M. Bao, and P.J. Lucassen The stress system in the human brain in depression and neurodegeneration Ageing Res. Rev. 4 2005 141 194
160. A.M. Bao, G. Meynen, and D.F. Swaab The stress system in depression and neurodegeneration: focus on the human hypothalamus Brain Res. Rev. 57 2008 531 553
161. R.W. Irwin, J.M. Wang, S. Chen, and R.D. Brinton Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease Front. Endocrinol. 2 2011 117
162. F. Bernardi, A. Lanzone, R.M. Cento, R.S. Spada, I. Pezzani, A.D. Genazzani, and et al. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia Eur. J. Endocrinol. 142 2000 466 471
163. C.D. Smith, D.R. Wekstein, W.R. Markesbery, and C.A. Frye 3alpha,5alpha-THP: a potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia Psychopharmacology 186 2006 481 485
164. D.A. Finn, and K.W. Gee The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid J. Pharmacol. Exp. Ther. 271 1994 164 170
165. J.C. Naylor, J.D. Kilts, C.M. Hulette, D.C. Steffens, D.G. Blazer, J.F. Ervin, and et al. Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects Biochim. Biophys. Acta 1801 2010 951 959
166. C.E. Marx, W.T. Trost, L.J. Shampine, R.D. Stevens, C.M. Hulette, D.C. Steffens, and et al. The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease Biol. Psychiatry 60 2006 1287 1294
167. S. Weill-Engerer, J.P. David, V. Sazdovitch, P. Liere, B. Eychenne, A. Pianos, and et al. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and non-demented patients J. Clin. Endocrinol. Metab. 87 2002 5138 5143
168. S. Luchetti, K. Bossers, S. Van de Bilt, V. Agrapart, R.R. Morales, G.V. Frajese, and et al. Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease Neurobiol. Aging 32 2011 1964 1976
169. N.A. Compagnone, and S.H. Mellon Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development See comments Proc. Natl. Acad. Sci. USA 95 1998 4678 4683
170. L. Starka, M. Duskova, and M. Hill Dehydroepiandrosterone: a neuroactive steroid J. Steroid Biochem. Mol. Biol. 145 2015 254 260
171. A. Cardounel, W. Regelson, and M. Kalimi Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action Soc. Exp. Biol. Med. 222 1999 145 149
172. M. Vallee, W. Mayo, and M. Le Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging Brain Res. Rev. 37 2001 301 312
173. R.C. Brown, Z. Han, C. Cascio, and V. Papadopoulos Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology Neurobiol. Aging 24 2003 57 65
174. S.B. Kim, M. Hill, Y.T. Kwak, R. Hampl, D.H. Jo, and R. Morfin Neurosteroids: cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics J. Clin. Endocrinol. Metab. 88 2003 5199 5206
175. L.M. Garcia-Segura, S. Veiga, A. Sierra, R.C. Melcangi, and I. Azcoitia Aromatase: a neuroprotective enzyme Prog. Neurobiol. 71 2003 31 41
176. T.A. Ishunina, D. van Beurden, G. van der Meulen, U.A. Unmehopa, E.M. Hol, I. Huitinga, and et al. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease Neurobiol. Aging 26 2005 173 194
177. E.R. Rosario, L. Chang, E.H. Head, F.Z. Stanczyk, and C.J. Pike Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease Neurobiol. Aging 32 2011 604 613
178. E.R. Rosario, L. Chang, F.Z. Stanczyk, and C.J. Pike Age-related testosterone depletion and the development of Alzheimer disease JAMA 292 2004 1431 1432
179. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, and et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
180. D. Caruso, A.M. Barron, M.A. Brown, F. Abbiati, P. Carrero, C.J. Pike, and et al. Age-related changes in neuroactive steroid levels in 3xTg-AD mice Neurobiol. Aging 34 2013 1080 1089
181. A.M. Barron, L.M. Garcia-Segura, D. Caruso, A. Jayaraman, J.W. Lee, R.C. Melcangi, and et al. Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease J. Neurosci. 33 2013 8891 8897
182. M.A. Friese, B. Schattling, and L. Fugger Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis Nat. Rev. Neurol. 10 2014 225 238
183. M. Filippi, M.A. Rocca, M.A. Horsfield, S. Hametner, J.J. Geurts, G. Comi, and et al. Imaging cortical damage and dysfunction in multiple sclerosis JAMA Neurol. 70 2013 556 564
184. N. Baumann, and D. Pham-Dinh Biology of oligodendrocyte and myelin in the mammalian central nervous system Physiol. Rev. 81 2001 871 927
185. C. Matute Glutamate and ATP signalling in white matter pathology J. Anat. 219 2011 53 64
186. M. Domercq, A. Perez-Samartin, D. Aparicio, E. Alberdi, O. Pampliega, and C. Matute P2X7 receptors mediate ischemic damage to oligodendrocytes Glia 58 2010 730 740
187. A.H. Crawford, J.H. Stockley, R.B. Tripathi, W.D. Richardson, and R.J. Franklin Oligodendrocyte progenitors: adult stem cells of the central nervous system? Exp. Neurol. 260 2014 50 55
188. R.J. Franklin, C. FFrench-Constant, J.M. Edgar, and K.J. Smith Neuroprotection and repair in multiple sclerosis Nat. Rev. Neurol. 8 2012 624 634
189. M. Kipp, S. Amor, R. Krauth, and C. Beyer Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender Front. Neuroendocrinol. 33 2012 1 16
190. M.S. Ghandour, R.R. Voskuhl, and M. Schumacher The androgen receptor as a therapeutic target for myelin repair in demyelinating diseases Expert Rev. Endocrinol. Metab. 9 2014 5 7
191. R. Hussain, M. El-Etr, O. Gaci, J. Rakotomamonjy, W.B. Macklin, N. Kumar, and et al. Progesterone and nestorone facilitate axon remyelination: a role for progesterone receptors Endocrinology 152 2011 3820 3831
192. R.D. Spence, M.E. Hamby, E. Umeda, N. Itoh, S. Du, A.J. Wisdom, and et al. Neuroprotection mediated through estrogen receptor-alpha in astrocytes Proc. Natl. Acad. Sci. USA 108 2011 8867 8872
193. R. Hussain, A.M. Ghoumari, B. Bielecki, J. Steibel, N. Boehm, P. Liere, and et al. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination Brain 136 2013 132 146
194. A.J. Khalaj, J. Yoon, J. Nakai, Z. Winchester, S.M. Moore, T. Yoo, and et al. Estrogen receptor (ER) beta expression in oligodendrocytes is required for attenuation of clinical disease by an ERbeta ligand Proc. Natl. Acad. Sci. USA 110 2013 19125 19130
195. M. El-Etr, M. Rame, C. Boucher, A.M. Ghoumari, N. Kumar, P. Liere, and et al. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex Glia 63 2015 104 117
196. P. Acs, M. Kipp, A. Norkute, S. Johann, T. Clarner, A. Braun, and et al. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice Glia 57 2009 807 814
197. J.Y. Lee, S.Y. Choi, T.H. Oh, and T.Y. Yune 17beta-Estradiol inhibits apoptotic cell death of oligodendrocytes by inhibiting RhoA-JNK3 activation after spinal cord injury Endocrinology 153 2012 3815 3827
198. S. Kumar, R. Patel, S. Moore, D.K. Crawford, N. Suwanna, M. Mangiardi, and et al. Estrogen receptor beta ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis Neurobiol. Dis. 56 2013 131 144
199. H. Offner Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis J. Neurosci. Res. 78 2004 603 624
200. K.M. Palaszynski, K.K. Loo, J.F. Ashouri, H.B. Liu, and R.R. Voskuhl Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis J. Neuroimmunol. 146 2004 144 152
201. L. Garay, M.C. Gonzalez Deniselle, L. Gierman, M. Meyer, A. Lima, P. Roig, and et al. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis NeuroImmunoModulation 15 2008 76 83
202. L. Garay, M.C. Deniselle, M. Meyer, J.J. Costa, A. Lima, P. Roig, and et al. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis Brain Res. 1283 2009 177 185
203. R.D. Spence, and R.R. Voskuhl Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration Front. Neuroendocrinol. 33 2012 105 115
204. H. Lassmann Models of multiple sclerosis: new insights into pathophysiology and repair Curr. Opin. Neurol. 21 2008 242 247
205. K.D. Pavelko, B.G. van Engelen, and M. Rodriguez Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination J. Neurosci. 18 1998 2498 2505
206. D.M. Chari, C. Zhao, M.R. Kotter, W.F. Blakemore, and R.J. Franklin Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system J. Neurosci. Res. 83 2006 594 605
207. J.M. Lee, P. Yan, Q. Xiao, S. Chen, K.Y. Lee, C.Y. Hsu, and et al. Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury J. Neurosci. 28 2008 3141 3149
208. J. Xu, S. Chen, H. Chen, Q. Xiao, C.Y. Hsu, D. Michael, and et al. STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes J. Neurosci. 29 2009 2022 2026
209. I. Huitinga, Z.A. Erkut, D. van Beurden, and D.F. Swaab The hypothalamo-pituitary-adrenal axis in multiple sclerosis Ann. NY Acad. Sci. 992 2003 118 128
210. Z.A. Erkut, E. Endert, I. Huitinga, and D.F. Swaab Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis Mult. Scler. 8 2002 229 236
211. C. Heidbrink, S.F. Hausler, M. Buttmann, M. Ossadnik, H.M. Strik, A. Keller, and et al. Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11beta-hydroxysteroid dehydrogenases in multiple sclerosis: implications for lesion pathogenesis Brain Behav. Immun. 24 2010 975 984
212. D. Caruso, M. Melis, G. Fenu, S. Giatti, S. Romano, M. Grimoldi, and et al. Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients J. Neurochem. 130 2014 591 597
213. F. Noorbakhsh, K.K. Ellestad, F. Maingat, K.G. Warren, M.H. Han, L. Steinman, and et al. Impaired neurosteroid synthesis in multiple sclerosis Brain 134 2011 2703 2721
214. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
215. F. Noorbakhsh, G.B. Baker, and C. Power Allopregnanolone and neuroinflammation: a focus on multiple sclerosis Front. Cell. Neurosci. 8 2014 134
216. S. Luchetti, C.G. van Eden, K. Schuurman, M.E. van Strien, D.F. Swaab, and I. Huitinga Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions J. Neuropathol. Exp. Neurol. 73 2014 123 135
217. D.J. Daugherty, V. Selvaraj, O.V. Chechneva, X.B. Liu, D.E. Pleasure, and W. Deng A TSPO ligand is protective in a mouse model of multiple sclerosis EMBO Mol. Med. 5 2013 891 903
218. A.F. De Nicola, M.C. Gonzalez Deniselle, L. Garay, M. Meyer, G. Gargiulo-Monachelli, R. Guennoun, and et al. Progesterone protective effects in neurodegeneration and neuroinflammation J. Neuroendocrinol. 25 2013 1095 1103
219. S. Johann, and C. Beyer Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia J. Steroid. Biochem. Mol. Biol. 2012
220. K.N. Fargo, E.M. Foecking, K.J. Jones, and D.R. Sengelaub Neuroprotective actions of androgens on motoneurons Front. Neuroendocrinol. 30 2009 130 141
221. M. Schumacher, R. Sitruk-Ware, and A.F. De Nicola Progesterone and progestins: neuroprotection and myelin repair Curr. Opin. Pharmacol. 8 2008 740 746
222. M. Schumacher, R. Guennoun, D.G. Stein, and A.F. De Nicola Progesterone: therapeutic opportunities for neuroprotection and myelin repair Pharmacol. Ther. 116 2007 77 106
223. S. Suzuki, C.M. Brown, and P.M. Wise Neuroprotective effects of estrogens following ischemic stroke Front. Neuroendocrinol. 30 2009 201 211
224. C.L. Gibson, L.J. Gray, P.M. Bath, and S.P. Murphy Progesterone for the treatment of experimental brain injury; a systematic review Brain 131 2008 318 328
225. F. di Michele, D. Lekieffre, A. Pasini, G. Bernardi, J. Benavides, and E. Romeo Increased neurosteroids synthesis after brain and spinal cord injury in rats Neurosci. Lett. 284 2000 65 68
226. A.B. Lopez-Rodriguez, E. Acaz-Fonseca, S. Giatti, D. Caruso, M.P. Viveros, R.C. Melcangi, and et al. Correlation of brain levels of progesterone and dehydroepiandrosterone with neurological recovery after traumatic brain injury in female mice Psychoneuroendocrinology 56 2015 1 11
227. M. Lorenzo, R. Peino, A.I. Castro, M. Lage, V. Popovic, C. Dieguez, and et al. Hypopituitarism and growth hormone deficiency in adult subjects after traumatic brain injury: who and when to test Pituitary 8 2005 233 237
228. Z. Olivecrona, P. Dahlqvist, and L.O. Koskinen Acute neuro-endocrine profile and prediction of outcome after severe brain injury Scand. J. Trauma Resusc. Emerg. Med. 21 2013 33
229. D. Meffre, A. Pianos, P. Liere, B. Eychenne, A. Cambourg, M. Schumacher, and et al. Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry Endocrinology 148 2007 2505 2517
230. J.A. Garringer, C. Niyonkuru, E.H. McCullough, T. Loucks, C.E. Dixon, Y.P. Conley, and et al. Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI J. Neurotrauma 30 2013 1415 1425
231. A.K. Wagner, E.H. McCullough, C. Niyonkuru, H. Ozawa, T.L. Loucks, J.A. Dobos, and et al. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury J. Neurotrauma 28 2011 871 888
232. M. Santarsieri, C. Niyonkuru, E.H. McCullough, J.A. Dobos, C.E. Dixon, S.L. Berga, and et al. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury J. Neurotrauma 31 2014 699 712
233. F. Labombarda, A. Pianos, P. Liere, B. Eychenne, S. Gonzalez, A. Cambourg, and et al. Injury elicited increase in spinal cord neurosteroid content analysed by gas chromatography mass spectrometry Endocrinology 147 2006 1847 1859
234. C. Gonzalez Deniselle, J.J. Lopez Costa, J.P. Saavedra, L. Pietranera, S.L. Gonzalez, L. Garay, and et al. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease Neurobiol. Dis. 11 2002 457 468
235. M. Meyer, M.C. Gonzalez Deniselle, G. Gargiulo-Monachelli, L.I. Garay, M. Schumacher, R. Guennoun, and et al. Progesterone effects on neuronal brain-derived neurotrophic factor and glial cells during progression of Wobbler mouse neurodegeneration Neuroscience 201 2012 267 279
236. T.M. Saleh, B.J. Connell, C. Legge, and A.E. Cribb Stroke-induced changes in estrogen release and neuronal activity in the parabrachial nucleus of the male rat J. Stroke Cerebrovasc. Dis. 13 2004 24 34
237. V. Scarabin-Carre, S. Brailly-Tabard, M.L. Ancelin, C. Maubaret, A. Guiochon-Mantel, M. Canonico, and et al. Plasma estrogen levels, estrogen receptor gene variation, and ischemic arterial disease in postmenopausal women: the three-city prospective cohort study J. Clin. Endocrinol. Metab. 99 2014 E1539 E1546
238. T. Pappa, K. Vemmos, E. Mantzou, P. Savvari, K. Stamatelopoulos, and M. Alevizaki Estradiol levels predict short-term adverse health outcomes in postmenopausal acute stroke women Eur. J. Neurol. 19 2012 1300 1304
239. A. Liu, I. Margaill, S. Zhang, F. Labombarda, B. Coqueran, B. Delespierre, and et al. Progesterone receptors: a key for neuroprotection in experimental stroke Endocrinology 153 2012 3747 3757
240. E. Dudley, M. Yousef, Y. Wang, and W.J. Griffiths Targeted metabolomics and mass spectrometry Adv. Protein Chem. Struct. Biol. 80 2010 45 83
241. J.C. Rijk, A. Lommen, M.L. Essers, M.J. Groot, J.M. Van Hende, T.G. Doeswijk, and et al. Metabolomics approach to anabolic steroid urine profiling of bovines treated with prohormones Anal. Chem. 81 2009 6879 6888
242. S. Anizan, E. Bichon, F. Monteau, N. Cesbron, J.P. Antignac, and B. Le Bizec A new reliable sample preparation for high throughput focused steroid profiling by gas chromatography-mass spectrometry J. Chromatogr. A 1217 2010 6652 6660
243. R. Menon, J. Jones, P.R. Gunst, M. Kacerovsky, S.J. Fortunato, G.R. Saade, and et al. Amniotic fluid metabolomic analysis in spontaneous preterm birth Reprod. Sci. 21 2014 791 803
244. A. Parizek, M. Mikesova, R. Jirak, M. Hill, M. Koucky, A. Paskova, and et al. Steroid hormones in the development of postpartum depression Physiol. Res. 63 Suppl. 2 2014 S277 S282
245. A. Paskova, A. Parizek, M. Hill, M. Velikova, J. Kubatova, M. Duskova, and et al. Steroid metabolome in the umbilical cord: is it necessary to differentiate between arterial and venous blood? Physiol. Res. 63 2014 115 126